Placental Insufficiency Microcirculation Quantification by Ultrafast Doppler (MICRODOPPLER PLACENTA)

Sponsor
Nantes University Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT03860103
Collaborator
(none)
165
1
35.5
4.7

Study Details

Study Description

Brief Summary

To identify fetuses small for their gestational-age who have reached their appropriate growth potential from growth-restricted fetuses due to placental insufficiency is uneasy. Intra Uterine Growth Restriction (IUGR) increases the risk for indicated preterm delivery, neonatal mortality and morbidity. Therefore, improving the knowledge of the placental perfusion is essential to better identify and manage fetal chronic oxygen deprivation associated with placental insufficiency. Thus, the investigators propose to study placental microcirculation with a more efficient Doppler than conventional Doppler use in clinical practice. The Ultrafast Doppler is being able to map placental blood flow and could have potential impact in placental insufficiency diagnosis and prevention. Moreover, this Doppler could discriminate maternal and fetal vascularization.

The hypothesis is that Ultrafast Doppler could help clinician to diagnose and manage preeclampsia and IUGR during pregnancy.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    165 participants
    Observational Model:
    Case-Control
    Time Perspective:
    Prospective
    Official Title:
    Placental Insufficiency Microcirculation Quantification by Ultrafast Doppler: an Observational Prospective Study
    Actual Study Start Date :
    Apr 1, 2019
    Actual Primary Completion Date :
    Mar 16, 2022
    Actual Study Completion Date :
    Mar 16, 2022

    Outcome Measures

    Primary Outcome Measures

    1. Qualitative analysis (velocities) of intraplacental blood flow after acquisition of sequences in Ultrafast Doppler imaging [from the 12 week of gestation]

    2. Quantitative analysis (flow rates) of intraplacental blood flow after acquisition of sequences in Ultrafast Doppler [from the 12 week of gestation]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 60 Years
    Sexes Eligible for Study:
    Female
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Patient who accepted to participate in the study

    • Woman over 18 years old

    • Affiliated to a social security scheme

    • Mono-fetal pregnancy

    • Patients with normal pregnancy between 11 and 42 weeks of amenorrhea

    • Patients hospitalized for preeclampsia and / or intrauterine growth retardation, beyond 20 weeks of amenorrhea

    Exclusion Criteria:
    • Minors, adults under guardianship, protected persons

    • Not affiliated to a social security scheme

    • Multiple pregnancy

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Nantes University Hospital Nantes France 44093

    Sponsors and Collaborators

    • Nantes University Hospital

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Nantes University Hospital
    ClinicalTrials.gov Identifier:
    NCT03860103
    Other Study ID Numbers:
    • RC19_0049
    First Posted:
    Mar 1, 2019
    Last Update Posted:
    Mar 17, 2022
    Last Verified:
    Mar 1, 2022
    Individual Participant Data (IPD) Sharing Statement:
    Undecided
    Plan to Share IPD:
    Undecided
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Nantes University Hospital
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Mar 17, 2022